Research department, The George Institute for Global Health, Research Department, 308-309, Elegance Tower, Plot No. 8, Jasola District Centre, New Delhi 110025, India.
Department of Medicine, University of New South Wales, 18 High Street, Kensington, New South Wales 2052, Australia.
Health Policy Plan. 2021 Sep 9;36(8):1316-1324. doi: 10.1093/heapol/czab053.
Intensified Mission Indradhanush (IMI) was a strategic endeavour launched by the Government of India aiming to achieve 90% full immunization coverage in the country by 2018. The basic strategy of this special drive involved identifying missed children and vaccinating them in temporary outreach sites for 1 week over consecutive 4-month period starting from October 2017. This study estimated the incremental economic and financial cost of conducting IMI in India from a government provider perspective. Five states-Assam, Bihar, Maharashtra, Rajasthan and Uttar Pradesh were purposefully selected because of high concentration of IMI activities. The stratified random sample of 40 districts, 90 sub-districts and 289 sub-centres were included in this study. Cost data were retrospectively collected at all levels from administrative records, financial records and staff interviews involved in IMI. The weighted incremental economic cost per dose (including vaccine costs) was lowest in Uttar Pradesh (US$3.45) and highest in Maharashtra (U$12.23). Incremental economic cost per IMI dose was found to be higher than a recent routine immunization costing study by Chatterjee and colleagues in 2018, suggesting that it requires additional resources to immunize children through an intensified push in hard-to-reach areas. Incremental financial cost of the IMI programme estimated in this study will be helpful for the government for any future planning of such special initiative. The reasons for variation of unit costs of IMI across the study districts are not known, but lower baseline coverage, high population density, migration, geography and terrain and vaccinating small numbers of children per session could account for the range of findings. Further analysis is required to understand the determinants of cost variations of the IMI programme, which may aid in better planning and more efficient use of resources for future intensified efforts.
强化免疫使命行动(IMI)是印度政府发起的一项战略努力,旨在到 2018 年实现全国 90%的儿童完全免疫接种率。该特别行动的基本策略包括确定漏种儿童,并在临时外展点接种疫苗,为期 1 周,连续 4 个月,从 2017 年 10 月开始。本研究从政府提供者的角度估计了在印度开展 IMI 的额外经济和财务成本。选择阿萨姆邦、比哈尔邦、马哈拉施特拉邦、拉贾斯坦邦和北方邦这五个邦是因为这些邦的 IMI 活动高度集中。本研究包括了分层随机选择的 40 个区、90 个分区和 289 个分区。成本数据是从与 IMI 相关的行政记录、财务记录和工作人员访谈中回顾性收集的。每剂(包括疫苗成本)的增量经济成本在北方邦最低(3.45 美元),在马哈拉施特拉邦最高(12.23 美元)。发现每剂 IMI 的增量经济成本高于 Chatterjee 及其同事在 2018 年进行的最近一次常规免疫成本研究,这表明在难以到达的地区通过强化推动免疫儿童需要额外的资源。本研究估计的 IMI 计划增量财务成本将有助于政府为未来的此类特别计划进行任何规划。研究地区 IMI 单位成本变化的原因尚不清楚,但较低的基线覆盖率、高人口密度、迁移、地理位置和地形以及每次接种的儿童人数较少,可能是造成这种差异的原因。需要进一步分析以了解 IMI 计划成本变化的决定因素,这可能有助于未来的强化努力更好地规划和更有效地利用资源。